SINT SINTX TECHNOLOGIES INC.

SINTX Technologies Announces Proposed Public Offering of Common Stock

SINTX Technologies Announces Proposed Public Offering of Common Stock

SALT LAKE CITY, UT, March 29, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, today announced that it intends to offer and sell shares of its common stock in a public offering. All shares of common stock in the offering are to be offered by SINTX. SINTX intends to use the net proceeds of the offering, if any, for working capital and general corporate purposes. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Maxim Group LLC is acting as sole placement agent, on a reasonable best efforts basis, for the proposed offering.

The public offering is being made pursuant to an effective shelf registration statement on Form S-3, as amended (File No. 333-274951), previously filed with the U.S. Securities and Exchange Commission (SEC) on October 12, 2023, as amended, and declared effective on November 27, 2023. The securities may be offered only by means of a prospectus. A preliminary prospectus supplement and the accompanying prospectus relating to and describing the terms of the public offering have been filed with the SEC, will form a part of the effective registration statement and will be available on the SEC’s website at . When available, copies of the preliminary prospectus supplement and accompanying prospectus relating to the public offering may also be obtained by contacting Maxim Group LLC, at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Prospectus Department, or by telephone at (212) 895-3745 or by email at .

This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About SINTX Technologies, Inc.

SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Over the past two years, SINTX has utilized strategic acquisitions and alliances to enter into new markets. The Company has manufacturing facilities in Utah and Maryland.

For more information on SINTX Technologies or its silicon nitride material platform, please visit .

Forward Looking Statement

This press release contains forward-looking statements, including those relating to the offering, within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA) that are subject to a number of risks and uncertainties. Risks and uncertainties that may cause such differences include, among other things: the timing of the offering, satisfaction of customary closing conditions related to the offering and sale of the shares of common stock, the use of proceeds from the offering, and SINTX’s ability to complete the offering; our ability to maintain the listing of our common stock on the Nasdaq Capital Market; factors affecting SINTX’s quarterly and annual results; SINTX’s ability to manage its growth; SINTX’s ability to achieve and sustain profitability; demand for SINTX’s products; SINTX’s ability to compete successfully; SINTX’s ability to rapidly develop and introduce new products; SINTX’s ability to develop and execute on successful business strategies; SINTX’s ability to comply with changes and applicable laws and regulations that are applicable to its businesses; SINTX’s ability to safeguard its intellectual property; SINTX’s success in defending legal proceedings brought against it; trends in the medical device industry; and general economic conditions. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations, and beliefs. There can be no assurance that any of the anticipated results will occur on a timely basis or at all due to certain risks and uncertainties, a discussion of which can be found in SINTX’s Risk Factors disclosure in the Registration Statement and SINTX’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 27, 2024, and in SINTX’s other filings with the SEC. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report.

Contact:

SINTX Technologies

801.839.3502



EN
29/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SINTX TECHNOLOGIES INC.

 PRESS RELEASE

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expa...

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms Appointment supports acceleration of revenue opportunities from SiNERGY™ silicon nitride devices and antipathogenic fibrous material technologies SALT LAKE CITY, Utah, Feb. 18, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon nitride (SiN) solutions for medical and other high-value applications, today announced the appointment of Ryan Elmore as President of SINTX T...

 PRESS RELEASE

SINTX Technologies to Participate in Noble Capital Markets’ Emerging G...

SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 SALT LAKE CITY, Utah, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon-nitride-based medical technologies, today announced that its management team will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference, to be held February 4–5, 2026. The Company’s participation comes at an important stage in its evolution, following a period o...

 PRESS RELEASE

SINTX Technologies to Participate in Sidoti & Company Investor Confere...

SINTX Technologies to Participate in Sidoti & Company Investor Conference SALT LAKE CITY, Utah, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), today announced that management will be presenting at Sidoti & Company’s Year End Virtual Investor Conference, held December 10-11, 2025. Sidoti's Year End Virtual Investor ConferenceDates: December 10-11, 2025Presentation Date and Time: Wednesday, December 10, 2025 at 3:15 P.M. ETWebcast: To schedule a one-on-one meeting with SINTX Technologies’ management team, please email KCSA Strategic ...

 PRESS RELEASE

SINTX Technologies, AI 적용한 3D 프린팅 환자 맞춤형 임플란트 위한 실리콘 나이트라이드–PEEK 복합소재 ...

SINTX Technologies, AI 적용한 3D 프린팅 환자 맞춤형 임플란트 위한 실리콘 나이트라이드–PEEK 복합소재 제조 위해 EVONIK과 계약 체결 SiN/PEEK 맞춤 장비 생산에 즉시 착수할 수 있게 돼 미국 유타주 솔트레이크시티, Dec. 02, 2025 (GLOBE NEWSWIRE) -- 첨단 세라믹과 생체소재 회사인 SINTX Technologies, Inc.(나스닥명: SINT) (이하 “SINTX” 또는 “회사”)가 특허를 획득한 실리콘 나이트라이드-PEEK 복합소재(SiN/PEEK) (미국 특허 제10,806,831호)를 제조하기 위해 고성능 폴리머 분야의 글로벌 선도 기업 Evonik Corporation(“EVONIK”)과 공급 계약을 체결했다. 이 소재는 SINTX의 미국 생산 설비에 이미 설치된 장비를 활용하고 AI를 적용해 생산될 예정인 환자 맞춤형 임플란트의 적층 제조를 위해 설계되었다. 이 계약에 따라 EVONIK은 상업 규모의 생산 역량을 활용해 Sin/PEEK 복합소재를 생산하게 되며, 이에 따라 회사는 AI 설계를 바탕으로 3D 프린팅한 환자 맞춤형 임플란트 제조를 즉시 시작할 수 있게 되었다. SIN...

 PRESS RELEASE

SINTX Technologies Menandatangani Perjanjian Bekalan dengan EVONIK unt...

SINTX Technologies Menandatangani Perjanjian Bekalan dengan EVONIK untuk Menghasilkan Sebatian Silikon Nitrida–PEEK untuk Implan Khusus Pesakit Berbantukan AI, Cetakan 3D Pencapaian ini membolehkan pengeluaran segera peranti tersuai SiN/PEEK SALT LAKE CITY, Utah, Dec. 02, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” atau “Syarikat”), sebuah syarikat seramik dan biobahan termaju, hari ini mengumumkan bahawa ia telah menandatangani perjanjian bekalan dengan Evonik Corporation (“EVONIK”), peneraju global dalam polimer berprestasi tinggi, untuk mengeluarkan seba...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch